Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Oct 20 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-oct-20-2023-7

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated October 20, 2023, titled "Zydus receives USFDA approval for ZITUVIOTM to treat adult patients with type 2 diabetes mellitus".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases